Jenny Chen, Ph.D. counsels both US and international clients in a wide-array of patent-related matters in the life science space, including prosecution, opinion, due diligence, licensing and post-grant proceedings. Her practice focuses on matters including antibodies, cell therapies, gene therapies, small molecule therapeutics, diagnosis and pharmaceutical formulations.
She is particularly experienced in strategic counseling on life cycle management of both biological and small molecule products.
Jenny leverages an in-depth understanding of the industries in which clients work. She has prior experience as a postdoctoral fellow in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital, Harvard Medical School. Her research focused on T cell activity in autoimmune diseases such as Type I diabetes.
